Phase 1 study of the anti-BCMA antibody-drug conjugate AMG 224 in patients with relapsed/refractory multiple myeloma

Authors
Publication date
1 January 2021
Publisher
'Springer Science and Business Media LLC'
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Crossref

      redirect
      Last time updated on 22/04/2021
      Sustaining member

      University of Miami: Scholarship Miami

      redirect
      oaioai:alma.01UOML_INST:114063489...
      Last time updated on 16/01/2024